Royal Bank of Canada’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-15,101
| Closed | -$6K | – | 7158 |
|
|
2020
Q1 | $6K | Buy |
15,101
+13,966
| +1,230% | +$5.05K | ﹤0.01% | 6016 |
|
|
2019
Q4 | $0 | Buy |
1,135
+225
| +25% | +$374 | ﹤0.01% | 7310 |
|
|
2019
Q3 | $2K | Sell |
910
-39
| -4% | -$79 | ﹤0.01% | 6361 |
|
|
2019
Q2 | $2K | Buy |
949
+166
| +21% | +$424 | ﹤0.01% | 6649 |
|
|
2019
Q1 | $2K | Sell |
783
-292
| -27% | -$945 | ﹤0.01% | 6588 |
|
|
2018
Q4 | $3K | Buy |
1,075
+400
| +59% | +$1.33K | ﹤0.01% | 6399 |
|
|
2018
Q3 | $3K | Sell |
675
-308
| -31% | -$1.36K | ﹤0.01% | 6473 |
|
|
2018
Q2 | $4K | Buy |
983
+308
| +46% | +$803 | ﹤0.01% | 6130 |
|
|
2018
Q1 | $2K | Sell |
675
-558
| -45% | -$882 | ﹤0.01% | 6155 |
|
|
2017
Q4 | $2K | Sell |
1,233
-656
| -35% | -$1.05K | ﹤0.01% | 6326 |
|
|
2017
Q3 | $4K | Buy |
1,889
+838
| +80% | +$2.85K | ﹤0.01% | 6483 |
|
|
2017
Q2 | $5K | Buy |
1,051
+199
| +23% | +$722 | ﹤0.01% | 6069 |
|
|
2017
Q1 | $3K | Sell |
852
-1,645
| -66% | -$4.85K | ﹤0.01% | 6384 |
|
|
2016
Q4 | $7K | Sell |
2,497
-13,078
| -84% | -$37.4K | ﹤0.01% | 6228 |
|
|
2016
Q3 | $48K | Sell |
15,575
-241
| -2% | -$879 | ﹤0.01% | 5178 |
|
|
2016
Q2 | $81K | Buy |
15,816
+241
| +2% | +$1.16K | ﹤0.01% | 4876 |
|
|
2016
Q1 | $64K | Sell |
15,575
-2,000
| -11% | -$10.7K | ﹤0.01% | 4997 |
|
|
2015
Q4 | $143K | Buy |
17,575
+13,467
| +328% | +$112K | ﹤0.01% | 4744 |
|
|
2015
Q3 | $34K | Buy |
4,108
+186
| +5% | +$1.71K | ﹤0.01% | 5337 |
|
|
2015
Q2 | $37K | Sell |
3,922
-1,660
| -30% | -$15.5K | ﹤0.01% | 5393 |
|
|
2015
Q1 | $52K | Sell |
5,582
-3,443
| -38% | -$33K | ﹤0.01% | 4955 |
|
|
2014
Q4 | $84K | Sell |
9,025
-34,784
| -79% | -$293K | ﹤0.01% | 4813 |
|
|
2014
Q3 | $391K | Buy |
43,809
+35,137
| +405% | +$256K | ﹤0.01% | 3693 |
|
|
2014
Q2 | $68K | Buy |
8,672
+17
| +0.2% | +$128 | ﹤0.01% | 4717 |
|
|
2014
Q1 | $68K | Buy |
8,655
+4,588
| +113% | +$36.9K | ﹤0.01% | 4722 |
|
|
2013
Q4 | $25K | Buy |
4,067
+1,486
| +58% | +$7.79K | ﹤0.01% | 5165 |
|
|
2013
Q3 | $9K | Sell |
2,581
-162
| -6% | -$369 | ﹤0.01% | 5472 |
|
|
2013
Q2 | $5K | Buy |
+2,743
| New | +$5.5K | ﹤0.01% | 5460 |
|
Royal Bank of Canada's CORV Position: Q2 2020 in Review
Royal Bank of Canada sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 15,101 shares — an estimated $6K sold.
Royal Bank of Canada first reported a position in CORV in Q2 2013 and held it in 28 quarters. The position peaked at $391K in Q3 2014. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.
- Royal Bank of Canada reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
- Royal Bank of Canada sold 15,101 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $6K.
- Royal Bank of Canada first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 28 quarters.
- Royal Bank of Canada's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $391K in Q3 2014.
- 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.
Based on Royal Bank of Canada's 13F filing for Q2 2020, filed 14 Aug 2020.